WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1994015603) USE OF IDAZOXAN AND ITS DERIVATIVES IN THE TREATMENT OF ALZHEIMER-TYPE SENILITY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1994/015603    International Application No.:    PCT/FR1994/000014
Publication Date: 21.07.1994 International Filing Date: 06.01.1994
Chapter 2 Demand Filed:    01.08.1994    
IPC:
A61K 31/415 (2006.01)
Applicants: PIERRE FABRE MEDICAMENT [FR/FR]; 45, place Abel-Gance, F-92100 Boulogne (FR) (For All Designated States Except US).
COLPAERT, Francis [FR/FR]; (FR) (For US Only).
IMBERT, Thierry [FR/FR]; (FR) (For US Only)
Inventors: COLPAERT, Francis; (FR).
IMBERT, Thierry; (FR)
Agent: AHNER, Francis; Cabinet Regimbeau, 26, avenue Kléber, F-75116 Paris (FR).
WARCOIN, Jacques; Cabinet Regimbeau, 26, avenue Kléber, F-75116 Paris (FR)
Priority Data:
93/00084 07.01.1993 FR
Title (EN) USE OF IDAZOXAN AND ITS DERIVATIVES IN THE TREATMENT OF ALZHEIMER-TYPE SENILITY
(FR) UTILISATION DE L'IDAZOXAN ET SES DERIVES POUR LE TRAITEMENT DE DEMENCE SENILE DU TYPE ALZHEIMER
Abstract: front page image
(EN)Use of a compound of general formula (I), wherein R is a hydrogen atom, a linear or branched C¿1?-C¿4? alkyl radical or a linear or branched C¿1?-C¿4? alkoxy radical, and its therapeutically acceptable salts, its racemic form or its optically active isomers. Said compound is useful in the preparation of a drug intended for use in the treatment of Alzheimer-type senility and pre-Alzheimer syndrome and the prevention of the progression of these diseases.
(FR)La présente invention concerne l'utilisation d'un composé de formule générale (I), dans laquelle R représente un atome d'hydrogène, un radical alkyle linéaire ou ramifié en C¿1?-C¿4? ou un radical alcoxy linéaire ou ramifié en C¿1?-C¿4? et ses sels thérapeutiquement acceptables, son racémique ou ses isomères optiquement actifs, pour la préparation d'un médicament destiné au traitement de démence sénile du type Alzheimer et du syndrome pré-Alzheimer ainsi que leur progression.
Designated States: AU, CA, JP, NZ, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: French (FR)
Filing Language: French (FR)